← Back to Clinical Trials
Recruiting NCT07020364

NCT07020364 Feasibility and Safety of a Single Working Element for Bipolar and Laser Enucleation in Prostate Surgery: A Prospective Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07020364
Status Recruiting
Phase
Sponsor Menoufia University
Condition Prostate
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2024-10-01
Primary Completion 2025-09-30

Eligibility & Interventions

Sex Male only
Min Age 50 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
A single working element for bipolar enucleationA single working element for laser enucleation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2024-10-01 with a primary completion date of 2025-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A prospective feasibility study would be a practical first step, focusing on real-time assessment and ensuring the new working element's integration is safe and effective before broader clinical trials.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with benign prostatic hyperplasia (BPH) requiring surgical intervention. * Prostate volume ≥40 cc (as assessed by transrectal ultrasound). * No prior history of prostate cancer. Exclusion Criteria: * Patients with ongoing urinary tract infections. * Prior prostate surgeries. * Coagulation disorders or patients on long-term anticoagulation therapy. * Known urethral strictures or other anatomical abnormalities complicating endoscopic procedures.

Contact & Investigator

Central Contact

Mohamed K Omar, Assistant professor

✉ kimo_81eg@yahoo.com

📞 +201066949454

Frequently Asked Questions

Who can join the NCT07020364 clinical trial?

This trial is open to male participants only, aged 50 Years or older, studying Prostate. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07020364 currently recruiting?

Yes, NCT07020364 is actively recruiting participants. Contact the research team at kimo_81eg@yahoo.com for enrollment information.

Where is the NCT07020364 trial being conducted?

This trial is being conducted at Shibīn al Kawm, Egypt.

Who is sponsoring the NCT07020364 clinical trial?

NCT07020364 is sponsored by Menoufia University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology